Literature DB >> 23571594

Molecular testing in thyroid cancer: BRAF mutation status and mortality.

Anne R Cappola, Susan J Mandel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23571594     DOI： 10.1001/jama.2013.3620

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Aberrant expression of PROS1 correlates with human papillary thyroid cancer progression.

Authors:  Jing Wang; Minxiang Lei; Zhijie Xu
Journal:  PeerJ       Date:  2021-08-03       Impact factor: 2.984

2.  BRAF V600E mutation and papillary thyroid cancer.

Authors:  Mingzhao Xing
Journal:  JAMA       Date:  2013-08-07       Impact factor: 56.272

3.  Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancy.

Authors:  Chunfang Hu; Weiwei Jing; Qing Chang; Zhihui Zhang; Zhenrong Liu; Jian Cao; Linlin Zhao; Yue Sun; Cong Wang; Huan Zhao; Ting Xiao; Huiqin Guo
Journal:  Mol Oncol       Date:  2022-03-12       Impact factor: 7.449

Review 4.  New insights into the diagnosis of nodular goiter.

Authors:  Anhelli Syrenicz; Monika Koziołek; Andrzej Ciechanowicz; Anna Sieradzka; Agnieszka Bińczak-Kuleta; Miłosz Parczewski
Journal:  Thyroid Res       Date:  2014-06-17

5.  BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer.

Authors:  Sang-Ah Han; Won Seo Park; Jae-Hoon Jang; Sun-Young Min; Jung Kyu Ryu; Jeong-Yoon Song
Journal:  Ann Surg Treat Res       Date:  2014-09-25       Impact factor: 1.859

6.  Not the same thing: metastatic PTCs have a different background than ATCs.

Authors:  Dario de Biase; Federica Torricelli; Moira Ragazzi; Benedetta Donati; Elisabetta Kuhn; Michela Visani; Giorgia Acquaviva; Annalisa Pession; Giovanni Tallini; Simonetta Piana; Alessia Ciarrocchi
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

7.  Using ultrasonographic features to predict the outcomes of patients with small papillary thyroid carcinomas: a retrospective study implementing the 2015 ATA patterns and ACR TI-RADS categories.

Authors:  Hee Min Park; Jihye Lee; Jin Young Kwak; Vivian Youngjean Park; Miribi Rho; Minah Lee; Jung Hyun Yoon
Journal:  Ultrasonography       Date:  2021-08-12

8.  Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas.

Authors:  Greta Gandolfi; Moira Ragazzi; Dario de Biase; Michela Visani; Eleonora Zanetti; Federica Torricelli; Valentina Sancisi; Mila Gugnoni; Gloria Manzotti; Luca Braglia; Silvio Cavuto; Domenico Franco Merlo; Giovanni Tallini; Andrea Frasoldati; Simonetta Piana; Alessia Ciarrocchi
Journal:  Oncotarget       Date:  2017-12-01

Review 9.  Update on Fundamental Mechanisms of Thyroid Cancer.

Authors:  Alessandro Prete; Patricia Borges de Souza; Simona Censi; Marina Muzza; Nicole Nucci; Marialuisa Sponziello
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-13       Impact factor: 5.555

10.  Value of Pyruvate Carboxylase in Thyroid Fine-Needle Aspiration Wash-Out Fluid for Predicting Papillary Thyroid Cancer Lymph Node Metastasis.

Authors:  Chang Liu; Lu Zhang; Yang Liu; Qingqing Zhao; Yu Pan; Yifan Zhang
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.